AGP Picks
View all

New Mexico Health Reporter
Provided by AGP

New Mexico Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Health Reporter.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on June 26, 2026

Nordic Naturals Ultimate Omega Featured in New Erewhon Smoothie by J Balvin
Jun. 26, 2026

Nordic Naturals Ultimate Omega Featured in New Erewhon Smoothie by J Balvin

Indeterminate GlobeNewswire
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc
Jun. 26, 2026

Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc

Indeterminate GlobeNewswire
Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease
Jun. 26, 2026

Monopar Presents New Analyses of Phase 3 FoCus Data at EAN 2026 Showing Greater Neurologic and Global Clinical Benefit with ALXN1840 Versus Standard of Care in Wilson Disease

Indeterminate GlobeNewswire
Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia
Jun. 26, 2026

Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia

Indeterminate GlobeNewswire
Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®
Jun. 26, 2026

Ascendis Joins Multiple Russell U.S. Indexes, Including the Russell 3000®, Russell 1000®, Russell 2500® and Russell Midcap®

Indeterminate GlobeNewswire
Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from the California Institute for Regenerative Medicine (CIRM) to Support Clinical Development of SRN-101 in High-Grade Glioma
Jun. 26, 2026

Siren Biotechnology Awarded $8M in Non-Dilutive Grant Funding from the California Institute for Regenerative Medicine (CIRM) to Support Clinical Development of SRN-101 in High-Grade Glioma

Indeterminate GlobeNewswire
Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units
Jun. 26, 2026

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

Indeterminate GlobeNewswire
FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable, Protect Public Health
Jun. 26, 2026

FDA Proposes Rule That Would Help Hold Foreign Tobacco Product Manufacturers Accountable, Protect Public Health

Indeterminate GlobeNewswire
Laboratory Information Management Systems (LIMS) Market Size Expected to Reach USD 5.19 Billion by 2030 | MarketsandMarkets™
Jun. 26, 2026

Laboratory Information Management Systems (LIMS) Market Size Expected to Reach USD 5.19 Billion by 2030 | MarketsandMarkets™

Indeterminate GlobeNewswire
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
Jun. 26, 2026

Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire
Cardiovascular Drugs Market to Reach New Heights by 2030, Driven by Rising Disease Prevalence and Innovation
Jun. 26, 2026

Cardiovascular Drugs Market to Reach New Heights by 2030, Driven by Rising Disease Prevalence and Innovation

Indeterminate GlobeNewswire
CIRM Advances $662 Million Research Budget, the Largest Annual Investment in Its History
Jun. 26, 2026

CIRM Advances $662 Million Research Budget, the Largest Annual Investment in Its History

Indeterminate GlobeNewswire
Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes
Jun. 26, 2026

Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes

Indeterminate GlobeNewswire
HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026
Jun. 26, 2026

HCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026

Indeterminate GlobeNewswire
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
Jun. 26, 2026

Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire
Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma
Jun. 26, 2026

Replimune Announces FDA Acceptance of RP1 Biologics License Application Resubmission for Advanced Melanoma

Indeterminate GlobeNewswire
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
Jun. 26, 2026

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker

Indeterminate GlobeNewswire
Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors
Jun. 26, 2026

Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors

Indeterminate GlobeNewswire
Complex Small Molecules Are Changing Drug R&D
Jun. 26, 2026

Complex Small Molecules Are Changing Drug R&D

Indeterminate GlobeNewswire
Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes
Jun. 26, 2026

Avalo Therapeutics to Join the Russell 2000® and Russell 3000® Indexes

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

New Mexico Health Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.